Ohcanbohtosat - Reenaers, C

  • Čájehuvvo 1 - 3 / 3
Aiddostahte ozu
  1. 1
    Are we giving biologics too much time? When should we stop treatment?

    Are we giving biologics too much time? When should we stop treatment? Dahkki Louis, Edouard, Belaiche, J, Reenaers, C

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Increased expression of receptor activator of NF-κB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients

    Increased expression of receptor activator of NF-κB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients Dahkki FRANCHIMONT, N, REENAERS, C, LAMBERT, C, BELAICHE, J, BOURS, V, MALAISE, M, DELVENNE, P, LOUIS, E

    Almmustuhtton 2004
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Early development of stricturing or penetrating pattern in Crohn’s disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype

    Early development of stricturing or penetrating pattern in Crohn’s disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype Dahkki Louis, E, Michel, V, Hugot, J P, Reenaers, C, Fontaine, F, Delforge, M, El Yafi, F, Colombel, J F, Belaiche, J

    Almmustuhtton 2003
    Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: